BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5563178)

  • 1. [Cytophotometric determination of DNA concentration in the process of malignant degeneration of serous ovarian cysts].
    Irzhanov SI
    Vopr Onkol; 1971; 17(3):52-4. PubMed ID: 5563178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of preoperative chemotherapy on the DNA content in ovarian serous cystadenocarcinomas].
    Irzhanov SI; Serov SF
    Vopr Onkol; 1981; 27(8):49-52. PubMed ID: 6792783
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mucopolysaccharides in tumors of the ovaries].
    Toreushina NS; Kozhevnikova IN; Zefirova NP
    Vopr Onkol; 1969; 15(8):37-40. PubMed ID: 4311343
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein PP12 in ovarian cyst fluid.
    Seppälä M; Than G
    Arch Gynecol Obstet; 1987; 241(1):33-5. PubMed ID: 2445309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
    Hazelton D; Nicosia RF; Nicosia SV
    Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein fractions of benign and malignant cystomas].
    Mettler L; Mäder C
    Z Geburtshilfe Gynakol; 1971; 174(1):58-74. PubMed ID: 5554805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
    Sun ZC
    Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asynchronous DNA synthesis and asynchronous mitosis in multinuclear ovarian cancer cells.
    Sheehy PF; Wakonig-Vaartaja T; Winn R; Clarkson BD
    Cancer Res; 1974 May; 34(5):991-6. PubMed ID: 4823909
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytophotometric study of papillary ovarian cystomas. Borderline cases of malignancy (author's transl)].
    Sachs H; Stegner HE; Würthner K
    Beitr Pathol; 1974 Jan; 151(1):42-64. PubMed ID: 4817524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ferritin levels of ascites and the contents of cystic ovarian tumors--possibilities of ferritin production and secretion by malignant tumor cells].
    Okamoto M; Fukasawa H; Hirata F; Hoshi S
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):240-6. PubMed ID: 6696460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
    Wahlberg K; Høyer-Hansen G; Casslén B
    Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A benign serous ovarian cystadenoma studied by chromosome and quantitative DNA analysis.
    Wager J; Granberg I; Vass L; Auer G
    Acta Cytol; 1977; 21(6):774-6. PubMed ID: 274883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression.
    Carico E; Chicchirichi R; Atlante M; Giovagnoli M; Vecchione A
    Anticancer Res; 1995; 15(2):631-4. PubMed ID: 7763049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle stimulating hormone binding inhibiting activity and inhibin properties of human ovarian cystic and porcine follicular fluid.
    Rettori V; Van Sickle M; Steinberger A; Asch RH
    Acta Eur Fertil; 1984; 15(2):93-7. PubMed ID: 6089484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer.
    Cobellis L; Reis FM; Luisi S; Danero S; Pirtoli L; Scambia G; Petraglia F
    J Soc Gynecol Investig; 2004 May; 11(4):203-6. PubMed ID: 15120692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological and histochemical changes in ovarian mucinous tumors. A study of 112 cases].
    Zhu YG
    Zhonghua Bing Li Xue Za Zhi; 1987 Dec; 16(4):272-4, 56. PubMed ID: 2968163
    [No Abstract]   [Full Text] [Related]  

  • 20. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
    Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.